Nexam Chemical Holding AB: Nexam Chemical carries out a rights issue of shares of approximately SEK 51.8 million, which is fully covered by subscription and underwriting commitments

Nexam Chemical carries out a rights issue of shares of approximately SEK 51.8 million, which is fully covered by subscription and underwriting commitments, with an over-allotment issue of up to an additional SEK 15.0 million and publishes preliminary financial information for the fourth quarter of 2025

The Board of Directors of Nexam Chemical Holding AB (publ) ("Nexam Chemical" or the "Company") has today, on 22 December 2025, subject to approval by a subsequent extraordinary general meeting to be held on 19 January 2026, resolved to carry out a new issue of shares with preferential rights for the Company's existing shareholders of approximately SEK 51.8 million (the "Rights Issue"). The Company has received subscription commitments totalling approximately SEK 11.4 million, corresponding to approximately 22.1 per cent of the Rights Issue, from the CEO, the CFO and all members of the Board of Directors, as well as from a number of the Company's larger shareholders, including Claes Mellgren, Per Olof Andersson, Sven-Olov Hjälmstad and Mats Andersson. In addition, the Company has entered into agreements regarding underwriting commitments totalling approximately SEK 40.4 million, corresponding to approximately 77.9 per cent of the Rights Issue. Accordingly, the Rights Issue is covered by subscription commitments and underwriting commitments totalling approximately SEK 51.8 million, corresponding to 100 per cent of the Rights Issue. The net proceeds from the Rights Issue are intended to be used to enable an accelerated commercial expansion within the Recycling business area and to strengthen the Company's financial flexibility. The Board of Directors has also resolved to propose that the extraordinary general meeting to be held on 19 January 2026 authorises the Board of Directors, to the extent the Board of Directors deems it appropriate, to resolve on an over-allotment issue of up to SEK 15.0 million in order to enable additional capital contributions and to ensure that the underwriters who have provided top underwriting commitments (the "Top Underwriters"), in the event of an oversubscription in the Rights Issue, are allotted shares corresponding to their underwriting commitments (the "Over-Allotment Issue"). The Rights Issue and the Over-Allotment Issue are subject to approval and, respectively, a resolution on authorisation by the extraordinary general meeting to be held on 19 January 2026, and notice of the extraordinary general meeting will be published through a separate press release. In connection with the Rights Issue, the Board of Directors of the Company has resolved to publish preliminary and unaudited financial information for the fourth quarter and the full year 2025. Based on the financial development to date, net sales for the fourth quarter of 2025 are expected to amount to approximately SEK 43.5 million, compared with SEK 48.6 million for the corresponding period in 2024. Of this amount, the Recycling business area is preliminarily estimated to have contributed approximately SEK 8.2 million, compared with approximately SEK 2.3 million for the corresponding period in 2024. See further under the section "Preliminary financial information for the fourth quarter and the full year 2025". Furthermore, the Board of Directors has resolved to bring forward the publication of the year-end report for 2025 to 23 January 2026.

Nexam Chemical's CEO Ronnie Törnqvist comments:

"During 2025, we have seen a clear breakthrough in our Recycling business, where demand is increasingly translating into actual volumes and recurring business. At the same time, the fourth quarter was affected by a combination of factors; a temporary inventory adjustment by a customer within the High Temperature business area contributed to a short-term impact on the Group's revenue. In other parts of the business, continued caution is also evident in certain parts of the value chain as a result of a more complex external environment. Despite this, EBITDA is at around break-even level and cash flow is slightly better than in the previous year. The rights issue provides us with the financial conditions to accelerate growth within the Recycling business in a market environment that we assess as favourable."

Background and rationale

Nexam Chemical develops and commercialises additives and solutions for the polymer industry, with a focus on improving material performance in plastics, including recycled polymers. Since 2023, the Company has carried out a strategic restructuring process focused on improved profitability, business quality and scalability, resulting in a more focused organisation, an improved product mix and a more diversified customer base.

During 2025, the Recycling business area has developed very positively, with increased delivery volumes and a growing number of commercial customer relationships. Against this background, the Board of Directors assesses that the Company's solutions have reached commercial maturity and that there are conditions for continued strong growth within the business area. Within the framework of the Company's current planning, and subject to prevailing market conditions and access to the necessary resources, the Company aims to double revenue within the Recycling business during 2026, and thereafter increase revenue at a corresponding rate during 2027.

The Board of Directors has therefore resolved to carry out the Rights Issue in order to provide the Company with additional financial resources to enable accelerated growth in a market environment that is assessed to be favourable and time-critical. Upon full subscription in the Rights Issue, the Company will receive approximately SEK 51.8 million before issue costs. The costs related to the Rights Issue are estimated to amount to approximately SEK 6.6 million, of which approximately SEK 3.0 million relates to underwriting fees (assuming that all underwriters elect to receive their underwriting compensation in cash). The expected net proceeds from the Rights Issue are therefore estimated to amount to approximately SEK 45.2 million. If the Rights Issue is oversubscribed, the Board of Directors may, to the extent the Board deems appropriate, carry out an Over-Allotment Issue of no more than 6,250,000 shares directed to the Top Underwriters, in order to enable additional capital contributions and to ensure that the Top Underwriters, in the event of an oversubscription in the Rights Issue, are allotted shares corresponding to their underwriting commitments. The subscription price in the Over-Allotment Issue will be the same as in the Rights Issue. If the Over-Allotment Issue is utilised in full, the Company will receive an additional SEK 15.0 million before issue costs. The net proceeds from the Rights Issue and, subject to its implementation, the Over-Allotment Issue, are intended to be used primarily to support the Company's continued development, with a focus on the rapidly growing Recycling business, through strengthening the commercial organisation, continued investments in additive technology and application-specific solutions, measures to strengthen market presence and communication, as well as for general corporate purposes and working capital in line with increasing volumes and business activity.

The Board of Directors assesses that a successfully completed Rights Issue may strengthen the Company's financial flexibility and create conditions to implement prioritised initiatives in line with the Company's strategic direction.

Summary of the Rights Issue

The Board of Directors of Nexam Chemical has today, on 22 December 2025, subject to approval by a subsequent extraordinary general meeting to be held on 19 January 2026, resolved to carry out the Rights Issue in accordance with the following principal terms:

• The Rights Issue comprises a maximum of 21,577,544 new shares in the Company.
• The subscription price in the Rights Issue amounts to SEK 2.40 per share.
• Upon full subscription of shares in the Rights Issue, the Company will receive approximately SEK 51.8 million, before deduction of issue costs, which are estimated to amount to approximately SEK 6.6 million, of which underwriting compensation amounts to approximately SEK 3.0 million, assuming that all underwriters elect to receive cash compensation.
• Shareholders who are registered in the share register maintained by Euroclear Sweden AB as of the record date on 22 January 2026 will have preferential rights to subscribe for shares in the Rights Issue. Existing shareholders as of the record date will be allocated one (1) subscription right for each one (1) existing share. Fifteen (15) subscription rights entitle the holder to subscribe for four (4) new shares.
• The subscription period in the Rights Issue will run from 26 January 2026 up to and including 9 February 2026.
• Approximately 22.1 per cent of the Rights Issue is covered by subscription commitments and approximately 77.9 per cent by underwriting commitments, of which approximately SEK 20.0 million constitutes a so-called bottom underwriting and approximately SEK 20.4 million constitutes a so-called top underwriting. Neither the subscription commitments nor the underwriting commitments are secured by bank guarantee, escrow arrangements, pledges or similar arrangements.
• Subscription commitments have been entered into by the CEO, the CFO and all members of the Board of Directors, as well as a number of the Company's larger existing shareholders. The underwriting commitments have been provided by both existing shareholders and external investors. The existing shareholders Claes Mellgren, Per Olof Andersson, Sven-Olov Hjälmstad and Mats Andersson have undertaken to subscribe for their entire pro rata shares in the Rights Issue and have, in addition, entered into top underwriting agreements, which entails an increased commitment in the Rights Issue.
• In the event that the Rights Issue is oversubscribed, the Board of Directors may, to the extent the Board deems appropriate, carry out an Over-Allotment Issue of no more than 6,250,000 shares, corresponding to SEK 15.0 million before issue costs, directed to the Top Underwriters, in order to enable additional capital contributions and to ensure that the Top Underwriters, in the event of an oversubscription in the Rights Issue, are allotted shares corresponding to their underwriting commitments. The subscription price in the Over-Allotment Issue will be the same as in the Rights Issue.
• The Rights Issue and the Over-Allotment Issue are subject to approval and, respectively, a resolution on authorisation by the extraordinary general meeting to be held on 19 January 2026.

The Company will prepare an information document (the "Information Document") in accordance with Article 1.4 db of Regulation (EU) 2017/1129 of the European Parliament and of the Council (the "Prospectus Regulation"). The terms and conditions of the Rights Issue will be set out in the Information Document, which is expected to be published on the Company's website on or about 23 January 2026.

If not all shares are subscribed for by exercise of subscription rights, allotment of the remaining shares shall be made within the highest amount of the Rights Issue: firstly, to those who have subscribed for shares by exercise of subscription rights (regardless of whether they were shareholders on the record date or not) and who have applied for subscription of shares without exercise of subscription rights and if allotment to these cannot be made in full, allotment shall be made pro rata in relation to the number of subscription rights that each and every one of those, who have applied for subscription of shares without exercise of subscription rights, have exercised for subscription of shares; secondly, to those who have applied for subscription of shares without exercise of subscription rights and if allotment to these cannot be made in full, allotment shall be made pro rata in relation to the number of shares the subscriber in total has applied for subscription of; and thirdly, to those who have provided underwriting commitments with regard to subscription of shares, in proportion to such underwriting commitments. To the extent that allotment in any section above cannot be done pro rata, allotment shall be determined by drawing of lots.

Preliminary timetable for the Rights Issue

20 January 2026	Last day of trading in the Company's shares including the right to receive subscription rights.
21 January 2026	First day of trading in the Company's shares without the right to receive subscription rights.
22 January 2026	Record date for participation in the Rights Issue. Shareholders who are registered in the share register maintained by Euroclear Sweden AB on this date will receive subscription rights for participation in the Rights Issue.
26 January - 4 February 2026	Trading in subscription rights (TR) on Nasdaq First North Premier Growth Market.
26 January - 9 February 2026	Subscription period for the Rights Issue.
26 January - 27 February 2026	Expected trading in paid subscribed shares (BTA) on Nasdaq First North Premier Growth Market.
11 February 2026	Expected date for announcement of the outcome of the Rights Issue.
Week 9, 2026	Registration of the Rights Issue with the Swedish Companies Registration Office (Bolagsverket).

Preliminary financial information for the fourth quarter and the full year 2025

In order to provide an updated view of the development of the business ahead of the Rights Issue, Nexam Chemical hereby publishes preliminary and unaudited financial information for the fourth quarter (1 October - 31 December) and the full year (1 January - 31 December) 2025.

During the fourth quarter, the Company's revenue development was affected by a combination of factors. Within the High Temperature business area, a temporary inventory adjustment at a major customer contributed to slightly lower total revenues compared with the corresponding period of the previous year. The effect is assessed to be of a non-recurring nature and is not expected to affect the Company's long-term market position within this business area. Within the application areas Aesthetics (colour masterbatches) and Light Weight (lightweight and strong structural foams), a certain degree of restraint has also been observed in parts of the value chain as a result of a more complex macroeconomic environment. Despite these temporary challenges, cash flow for the quarter is in line with the previous year and EBITDA is at a level around break-even. The Company holds a strong position across all business areas and continues to actively adapt its offering, customer dialogue and resource allocation, with a continued focus on profitability, business quality and long-term value creation.

All figures below relate to the Group and are unaudited. Comparative figures in parentheses refer to the corresponding period of the previous year.

Fourth quarter 2025 (1 October - 31 December)

• Net sales are preliminarily estimated to amount to approximately SEK 43.5 million (48.6).
• Net sales for the Recycling business are preliminarily estimated to amount to approximately SEK 8.2 million (2.3).
• Gross margin is preliminarily estimated to amount to approximately 46 per cent (47).
• EBITDA is preliminarily estimated to amount to approximately SEK 0 million (2).
• Cash flow from operating activities is preliminarily estimated to amount to approximately SEK -1.0 million (-1.6).
• Total cash flow (net cash flow) is preliminarily estimated to amount to approximately SEK -3.0 million (-5.5).

Full year 2025 (1 January - 31 December)

• Net sales are preliminarily estimated to amount to approximately SEK 192.6 million (199.6).
• Net sales for the Recycling business are preliminarily estimated to amount to approximately SEK 23.0 million (7.3).
• Gross margin is preliminarily estimated to amount to approximately 46 per cent (46).
• EBITDA is preliminarily estimated to amount to approximately SEK 3.3 million (8.1).
• Cash flow from operating activities is preliminarily estimated to amount to approximately SEK 7.8 million (7.4).
• Total cash flow (net cash flow) is preliminarily estimated to amount to approximately SEK -3.4 million (-5.3).

Subscription commitments and underwriting commitments

The Company has received subscription commitments totalling approximately SEK 11.4 million, corresponding to approximately 22.1 per cent of the Rights Issue, from the CEO, the CFO and all members of the Board of Directors, as well as from a number of the Company's larger shareholders. In addition, the Company has entered into underwriting agreements totalling SEK 40.4 million, corresponding to approximately 77.9 per cent of the Rights Issue. Of the total underwriting commitments, approximately SEK 20.0 million relates to a bottom underwriting covering up to approximately 60.7 per cent of the Rights Issue, and approximately SEK 20.4 million constitutes a top underwriting for the interval from approximately 60.7 per cent up to 100 per cent. The top underwriting is a so-called top-down underwriting. The bottom underwriting may be called upon to the extent that the Rights Issue is not subscribed for in excess of approximately 60.7 per cent, and the top underwriting may be called upon to the extent that the Rights Issue is not subscribed for in excess of 100 per cent. The underwriting commitments have been provided by both existing shareholders and external investors. The existing shareholders Claes Mellgren, Per Olof Andersson, Sven-Olov Hjälmstad and Mats Andersson have undertaken to subscribe for their entire pro rata shares in the Rights Issue and have, in addition, entered into top underwriting agreements, which entails an increased commitment in the Rights Issue.

No compensation is payable for the subscription commitments provided. For the bottom underwriting, underwriting compensation will be payable either in the form of cash compensation corresponding to seven (7) per cent of the guaranteed amount or in the form of compensation in newly issued shares in the Company corresponding to seven (7) per cent of the guaranteed amount. For the top underwriting, underwriting compensation will be payable either in the form of cash compensation corresponding to eight (8) per cent of the guaranteed amount or in the form of compensation in newly issued shares in the Company corresponding to eight (8) per cent of the guaranteed amount. In order to enable the issue of shares as underwriting compensation to those underwriters who elect to receive underwriting compensation in the form of newly issued shares in the Company, the Board of Directors has proposed that the extraordinary general meeting to be held on 19 January 2026, inter alia, resolves on approval of the Rights Issue and authorises the Board of Directors to resolve on the issue of such shares to the underwriters (the "Compensation Issue"). The subscription price per share in the Compensation Issue shall correspond to the volume-weighted average price (VWAP) of the Company's share on Nasdaq First North Premier Growth Market during the subscription period in the Rights Issue, but shall never be lower than the subscription price in the Rights Issue.

Neither the subscription commitments nor the underwriting commitments are secured by bank guarantees, escrow arrangements, pledges or similar arrangements, and therefore there is a risk that the commitments, in whole or in part, will not be fulfilled.

Subscription for shares in the Rights Issue (other than pursuant to preferential rights) that results in an investor acquiring a shareholding corresponding to or exceeding a threshold of ten (10) per cent of the total number of votes in the Company following completion of the Rights Issue must, prior to the investment, be notified to the Swedish Inspectorate of Strategic Products (Inspektionen för Strategiska Produkter, "ISP") in accordance with the Swedish Act (2023:560) on the Screening of Foreign Direct Investments (the "FDI Act"). To the extent that an underwriter's fulfilment of its underwriting commitment entails a notification obligation under the FDI Act, such part of the underwriting commitment is conditional on notification that such notification has been left without action or that approval has been obtained from ISP.

The Over-Allotment Issue

In order to provide for the possibility of raising additional capital in the event that the Rights Issue is oversubscribed, the Board of Directors intends to propose that the extraordinary general meeting to be held on 19 January 2026 resolves to authorise the Board of Directors to, with deviation from the shareholders' preferential rights, resolve on a directed share issue of no more than 6,250,000 shares in the form of a so-called Over-Allotment Issue of up to SEK 15.0 million. The subscription price in the Over-Allotment Issue shall amount to SEK 2.40 per share, corresponding to the subscription price in the Rights Issue. The Over-Allotment Issue may be utilised by the Board of Directors, in whole or in part, in the event that the Rights Issue is oversubscribed and to the extent the Board of Directors deems it appropriate in relation to the prevailing share price and other market conditions. The purpose of the deviation from the shareholders' preferential rights is thus to be able, in the event of an oversubscription in the Rights Issue, to satisfy demand in excess of that originally anticipated. The right to subscribe for shares in the Over-Allotment Issue shall vest solely in the Top Underwriters in order to enable additional capital contributions and to ensure that the Top Underwriters, in the event of an oversubscription in the Rights Issue, are allotted shares corresponding to their underwriting commitments. Each Top Underwriter's subscription in the Over-Allotment Issue will therefore, provided that the relevant Top Underwriter elects to participate in the Over-Allotment Issue, amount to the difference between the relevant Top Underwriter's total underwriting commitment and its actual subscription within the framework of its respective underwriting commitment in the Rights Issue. If allotment to the Top Underwriters cannot be made in full through the Over-Allotment Issue, allotment within the highest amount of the Over-Allotment issue may instead be made in proportion to the top guarantee commitments made. The Board of Directors considers it to be in the interest of both the Company and its shareholders that the Company, where applicable, can be provided with additional capital in a time- and cost-efficient manner through the Over-Allotment Issue.

Change in the number of shares and share capital and dilution

Upon full subscription in the Rights Issue, and assuming that the Over-Allotment Issue is not utilised, the number of shares in the Company will increase by a maximum of 21,577,544 shares, from 80,915,798 shares to 102,493,342 shares, and the share capital will increase by a maximum of SEK 414,952.769242, from SEK 1,556,073.038501 to SEK 1,971,025.807743, corresponding to a maximum dilution effect of approximately 21.1 per cent of the total number of shares and votes in the Company.

Upon full subscription in the Rights Issue, and assuming that the Over-Allotment Issue is utilised in full, the number of shares in the Company will increase by a maximum of 27,827,544 shares, from 80,915,798 shares to 108,743,342 shares, and the share capital will increase by a maximum of SEK 535,145.076938, from SEK 1,556,073.038501 to SEK 2,091,218.115439, corresponding to a maximum dilution effect of approximately 25.6 per cent of the total number of shares and votes in the Company.

Underwriters who have provided underwriting commitments in the Rights Issue may receive compensation in the form of newly issued shares, which means that up to an additional 1,261,748 new shares may be issued through the Compensation Issue if all underwriters elect to receive compensation in shares, resulting in a further increase of the share capital by a maximum of SEK 24,264.384617. This entails an additional dilution effect of up to approximately 1.1 per cent, based on the number of shares in the Company following completion of the Rights Issue, assuming full subscription and assuming that the Over-Allotment Issue is utilised in full.

The maximum dilution effect that may arise through the Rights Issue, the Compensation Issue and the Over-Allotment Issue therefore amounts to approximately 26.4 per cent.

Information Document

No prospectus will be prepared in connection with the Rights Issue. The Company will prepare and publish the Information Document in the form prescribed by Annex IX to the Prospectus Regulation. The Information Document is expected to be published on the Company's website on or about 23 January 2026.

Bringing forward the publication of the year-end report for 2025

In connection with the Rights Issue, the Board of Directors of the Company has resolved to bring forward the publication of the year-end report for 2025 to 23 January 2026 instead of 29 January 2026 as previously communicated.

Advisers

Corpura Fondkommission AB, www.corpura.se, is acting as Sole Coordinator and Bookrunner in connection with the Rights Issue. Setterwalls Advokatbyrå AB is acting as legal adviser to the Company in connection with the Rights Issue.

For more information, please visit www.nexamchemical.com or contact:

Ronnie Törnqvist, CEO, [phone], [e-mail], or Cecilia Jinert Johansson, Chair of the Board, [phone], [e-mail].

This information constitutes information that Nexam Chemical is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the above contact persons, on 22 December 2025 at 08:30 CET.

IMPORTANT INFORMATION

The release, announcement or distribution of this press release may, in certain jurisdictions, be subject to legal restrictions. The recipients of this press release in jurisdictions where this press release has been published or distributed shall inform themselves of and follow such legal restrictions. The recipient of this press release is responsible for using this press release, and the information contained herein, in accordance with applicable rules in each jurisdiction.

This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in Nexam Chemical in any jurisdiction, neither from Nexam Chemical nor from someone else.

This press release is not a prospectus for the purposes of the Prospectus Regulation and has not been approved by any regulatory authority in any jurisdiction. No prospectus will be prepared in connection with the Rights Issue. The Company will prepare and publish an Information Document in the form provided for in Annex IX of the Prospectus Regulation before the subscription period in the Rights Issue begins. This press release does not identify or suggest, or purport to identify or suggest, the risks (direct or indirect) that may be associated with an investment in the Company. The information contained in this announcement relating to the Rights Issue is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this press release or its accuracy or completeness.

This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities in the United States. The securities referred to herein may not be sold in the United States absent registration or an exemption from registration under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public Rights Issue of the securities in the United States. The information in this press release may not be announced, published, copied, reproduced or distributed, directly or indirectly, in whole or in part, within or into the USA, Australia, Belarus, Canada, Hong Kong, Japan, New Zeeland, Russia, Singapore, South Africa, South Korea, Switzerland or in any other jurisdiction where such announcement, publication or distribution of the information would not comply with applicable laws and regulations or where such actions are subject to legal restrictions or would require additional registration or other measures than what is required under Swedish law. Actions taken in violation of this instruction may constitute a crime against applicable securities laws and regulations.

In the United Kingdom, this document and any other materials in relation to the securities described herein is only being distributed to, and is only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, "qualified investors" who are (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). In the United Kingdom, any investment or investment activity to which this communication relates is available only to, and will be engaged in only with, relevant persons. Persons who are not relevant persons should not take any action on the basis of this press release and should not act or rely on it.

Forward-looking statements

This press release contains forward-looking statements that reflect the Company's intentions, beliefs, or current expectations about and targets for the Company's and the group's future results of operations, financial condition, liquidity, performance, prospects, anticipated growth, strategies and opportunities and the markets in which the Company and the group operates. Forward-looking statements are statements that are not historical facts and may be identified by words such as "believe", "expect", "anticipate", "intend", "may", "plan", "estimate", "will", "should", "could", "aim" or "might", or, in each case, their negative, or similar expressions. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurances that they will materialize or prove to be correct. Because these statements are based on assumptions or estimates and are subject to risks and uncertainties, the actual results or outcome could differ materially from those set out in the forward-looking statements as a result of many factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The Company does not guarantee that the assumptions underlying the forward-looking statements in this press release are free from errors and readers of this press release should not place undue reliance on the forward-looking statements in this press release. The information, opinions and forward-looking statements that are expressly or implicitly contained herein speak only as of its date and are subject to change without notice. Neither the Company nor anyone else undertake to review, update, confirm or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this press release, unless it is required by law or Nasdaq First North Premier Growth Market's rule book for issuers.

Information to distributors

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the offered shares have been subject to a product approval process, which has determined that such shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment").

Notwithstanding the Target Market Assessment, distributors should note that: the price of the shares in the Company may decline and investors could lose all or part of their investment; the shares in the Company offer no guaranteed income and no capital protection; and an investment in the shares in the Company is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Rights Issue.

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the shares in the Company.

Each distributor is responsible for undertaking its own target market assessment in respect of the shares in the Company and determining appropriate distribution channels.

Foreign direct investments

As Nexam Chemical is deemed to carry out activities worthy of protection in accordance with the Swedish Screening of Foreign Direct Investments Act (Sw. lag (2023:560) om granskning av utländska direktinvesteringar), certain investments in the Rights Issue may require examination by the Inspectorate of Strategic Products. The Company will publish more information about this on the Company's website, www.nexamchemical.com, no later than in connection with the publication of the Information Document.

Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.

For further information please contact: Ronnie Törnqvist, VD, [phone], [e-mail]

Certified Adviser:

Bergs Securities AB, [e-mail]

This information is information that Nexam Chemical Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on 22^nd of December 2025.

About Nexam Chemical

Nexam Chemical develops technology and products that make it possible to significantly improve the production process and properties of most types of plastics in a cost-effective manner and with retained production technology. The improved properties include strength, toughness, temperature and chemical resistance as well as service life. The improvements in properties that can be achieved by using Nexam Chemical's technology make it possible to replace metals and other heavier or more expensive materials with plastics in a number of applications. In applications where plastic is already used, Nexam Chemicals products can improve the manufacturing process, reducing material use and enable more environmental friendly alternatives. Example of commercial applications: pipe manufacturing, foam production and high-performance plastics. More information about the business will be found on www.nexamchemical.com. The company's Certified Adviser is Bergs Securities AB. Bergs Securities AB can be reached at [e-mail] or by phone [phone].